clinical studylínchuáng yánjiū临床研究shows / indicatesxiǎnshì显示new drugxīn yào新药zorevunersen (epilepsy drug)Zuǒléifúnàsēn佐雷伏纳森to cause / makeshǐ使Dravet syndrome (severe epilepsy)Délāwéi Zōnghézhēng德拉韦综合征children with the diseasehuàn ér患儿epilepsy / seizuresdiānxián癫痫attacks / episodesfāzuò发作at mostzuì duō最多to reducejiǎnshǎo减少90 percentjiǔ chéng九成。
March 4, 2026 at 10:00 PM
New Words
News in English
Lifestyle & CultureClinical Trial Shows New Drug Zorevunersen Cuts Seizures by Up to 91 Percent in Children With Dravet Syndrome
Published in the New England Journal of Medicine, the study confirmed zorevunersen can reduce monthly seizure frequency in children with Dravet syndrome by up to 91 percent. The research team found the drug also improved cognitive function and quality of life over a three-year period, and has already launched a larger Phase 3 trial.
A clinical study published in the New England Journal of Medicine demonstrates that the novel drug zorevunersen can reduce epilepsy attacks in children with Dravet syndrome by as much as approximately 90 percent.
Dravet syndrome is a rare and severe hereditary epilepsy triggered by mutations in the SCN1A gene. Currently, there are no clinical treatments available to cure it completely.
This study enrolled a total of 81 children aged between 2 and 18 years with the disease. Participants experienced approximately 17 seizure episodes per month on average before receiving treatment.
The drug's mechanism of action involves increasing the production of protein from healthy copies of the SCN1A gene, thereby restoring nerve cell function.
The study also found that over a three-year trial period, the drug helped children with the disease improve their cognitive function and quality of life, with the majority experiencing relatively mild adverse reactions.
The positive preliminary results prompted the research team to launch a larger-scale phase 3 clinical trial, with patient enrollment expected to complete in the second quarter of 2026.
Analysts believe that if phase 3 data receives verification, zorevunersen may become the first disease-modifying therapy for Dravet syndrome patients, achieving milestone significance.
More in Lifestyle & Culture
EnglandYīnggélán英格兰extra time / overtimejiā shí sài加时赛to defeat / to beatjī bài击败NorwayNuówēi挪威，to advance / to qualify for the next stagejìnjí晋级the World Cupshìjièbēi世界杯the semifinalbànjuésài半决赛。
England Beat Norway 2-1 in Extra Time to Reach World Cup Semifinal
ArgentinaĀgēntíng阿根廷by a score of / withyǐ以three to one (score)3 bǐ 13比1to eliminate / to knock outtáotài淘汰SwitzerlandRuìshì瑞士，to advance / to progress to the next stagejìnjí晋级the World Cupshìjièbēi世界杯the top four / the semifinal stagesìqiáng四强。
Argentina Beat Switzerland 3-1 to Reach World Cup Semifinal
SpainXībānyá西班牙2-1 (score)liǎng bǐ yī两比一to eliminate / knock outtáotài淘汰BelgiumBǐlìshí比利时to advance to the next roundjìnjí晋级World CupShìjiè Bēi世界杯semifinalbànjuésài半决赛。
Spain Beat Belgium 2-1 to Reach World Cup Semifinal
CongoGāngguǒ刚果EbolaĀibólā埃博拉epidemic / outbreakyìqíng疫情death tollsǐwáng rénshù死亡人数to exceed / to surpasstūpò突破600liùbǎi六百，virusbìngdú病毒to spread tomànyán zhì蔓延至new provincesxīn shěngfèn新省份。
Congo Ebola Death Toll Tops 600 as Virus Spreads to New Provinces